Decidual and vascular pathophysiology in pregnancy compromise

Seminars in Reproductive Endocrinology

Volumn 17, Issue 1, 1999, Pages 63-72

  Starzyk, Kathryn A ^a   Pijnenborg, Robert ^b   Salafia, Carolyn M ^b  

^a College of Physicians and Surgeons ^*  (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTEGRIN; MATRIX METALLOPROTEINASE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLASMINOGEN ACTIVATOR INHIBITOR 2; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ATHEROSCLEROSIS; BLOOD CLOTTING; BLOOD VESSEL PERMEABILITY; CONFERENCE PAPER; DECIDUA; ENDOMETRIUM; FIBRINOLYSIS; HUMAN; INTRAUTERINE GROWTH RETARDATION; MYOMETRIUM; PATHOPHYSIOLOGY; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; THROMBOSIS; TROPHOBLAST; TUNICA MEDIA; VASCULAR DISEASE; VASCULITIS;

EID: 0033050198     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016213     Document Type: Conference Paper

References (113)

1. Robertson WB, Manning PJ. Elastic tissue in uterine blood vessels. J Pathol 1974;112:237
2. Hsu CC, Kuo HC, Wang ST, Huang KE. Interference with uterine blood flow by clomiphene citrate in women with unexplained infertility. Obstet Gynecol 1995;86:917-921
3. de Ziegler D, Bessis R, Frydman R. Vascular resistance of uterine arteries: Physiological effects of estradiol and progesterone. Fertil Steril 1991;55:775-779
4. Bing C, Johnson IR, Pipkin FB. Angiotensin receptors in myometrium and myometrial vessels from uteri of women during the follicular and luteal phases of the menstrual cycle and in late pregnancy. Clin Sci (Colch) 1996;90:499-505
5. Okahara K, Sun B, Kambayashi Ji. Upregulation of prostacyclin synthesis-related gene expression by shear stress in vascular endothelial cells. Arterioscler Thromb Vasc Biol 1998;18:1922-1926
6. Mancina R, Susini T, Renzetti A, Forti G, Razzoli E, Serio M, Maggi M. Sex steroid modulation of AT2 receptors in human myometrium. J Clin Endocrinol Metab 1996;81:1753-1757
7. Bassett JR, Cairncross KD. Changes in the coronary vascular system following prolonged exposure to stress. Pharmacol Biochem Behav 1977;6:3a-8
8. Singer CF, Marbaix E, Kokorine I, Lemoine P, Donnez J, Eeckhout Y, Courtoy PJ. Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids. Proc Natl Acad Sci USA 1997;94:10341-10345
9. Salamonsen LA, Woolley DE. Matrix metalloproteinases in normal menstruation. Hum Reprod 1996;11(Suppl)2:124-133
10. Loke YW, Butterworth BH. Heterogeneity of human trophoblast populations. In Gill TJ III, Wegmann TG, Nisbet-Brown E (eds). Immunoregulation and fetal survival. Oxford, UK: Oxford University Press, 1987:197-209
11. Pijnenborg R. The origin and future of placental bed research. Eur J Obstet Gynecol Reprod Biol 1998;81:185-190
12. Harris JWS, Ramsey EM. The morphology of human uteroplacental vasculature. Contrib Embryol Carnegie Inst 1966;38:43-58
13. Boyd JD, Hamilton WJ. Somite stages: the decidua capsularis. In The human placenta. Cambridge, UK: W. Heffer and Sons, 1970:chap 7
14. Craven CM, Morgan T, Ward K. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta 1998;19:241-252
15. Pijnenborg R, Bland JM, Robertson WB, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983;4:397-414
16. Pijnenborg R, Dixon G, Robertson WB, Brosens I. Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy. Placenta 1980;1:3-19
17. Brosens I, Robertson WB, Dixon HG. The physiological response of the vessels of the placental bed to normal pregnancy. J Pathol Bacteriol 1967;93:569-579
18. Matijevic R, Meekins JW, McFadyen IR, Pijnenborg R. Physiological changes of spiral arteries and blood flow in the placental bed during early pregnancy. Contemp Rev Obstet Gynaecol 1996;8:127-131
19. Christ GJ, Moerno AP, Parker ME, Goudre CM, Valcic M, Melman A, Spray DC. Intercellular communication through gap junctions: A potential role in pharmomechanical coupling and syncytial tissue cintraction in vascular smooth muscle isolated from the human corpus cavernosum. Life Sci 1991;49:PL195-PL200
20. Enders AC, Blankenship TN. Modification of endometrial arteries during invasion by cytotrophoblast cells in the pregnant macaque. Acta Anat (Basel) 1997;159:169-193
21. Brosens I. The utero-placental vessels at term - the distribution and extent of the physiological changes. Trophoblast Res 1988;3:61-67
22. Hustin J, Schaaps JP. Echographic and anatomic studies of the maternotrophoblastic border during the first trimester of pregnancy. Am J Obstet Gynecol 1987;157:162-168
23. Hustin J, Schaaps JP, Lambotte R. Anatomical studies of the uteroplacental vascularization in the first trimester of pregnancy. Troph Res 1988;3:49-60
24. Jaffe R. Investigation of abnormal first-trimester gestations by color Doppler imaging. J Clin Ultrasound 1993;21:521-526
25. Genbacev O, Joslin R, Damsky CH, Polliotti BM, Fisher SJ. Hypoxia alters early gestation human cytotrophoblast differentiation/invasion in vitro and models the placental defects that occur in preeclampsia. J Clin Invest 1996;97:540-550
26. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 1997;277:1669-1672
27. Khong TY, Tee JH, Kelly AJ. Absence of innervation of the uteroplacental arteries in normal and abnormal human pregnancies. Gynecol Obstet Invest 1997;43:89-93
28. Dickey RP, Hower JF. Relationship of estradiol and progesterone levels to uterine blood flow during early pregnancy. Early Pregnancy 1996;2:113-120
29. Karimu AL, Burton GJ. Significance of changes in fetal perfusion pressure to factors controlling angiogenesis in the human term placenta. J Reprod Fertil 1994;102:447-450
30. Faulk WP, Labarrere CA, Carson SD. Tissue factor: Identification and characterization of cell types in human placentae. Blood 1990;76:86-96
31. Thaler I, Amit A, Jakobi P, Itskovitz-Eldor J. The effect of isosorbide dinitrate on uterine artery and umbilical artery flow velocity waveforms at mid-pregnancy. Obstet Gynecol 1996;88:838-843
32. Nelson SH, Steinsland OS, Suresh MS, Lee NM. Pregnancy augments nitric oxide-dependent dilator response to acetylcholine in the human uterine artery. Hum Reprod 1998;13:1361-1367
33. Bataineh A, Raij L. Angiotensin II, nitric oxide, and end-organ damage in hypertension. Kidney Int 1998;68:(Suppl):S14-S19
34. Meekins JW, Pijnenborg R, Hanssens M, McFadyen IR, van Asshe A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe preeclamptic pregnancies using histological and immunohistochemical techniques. Br J Obstet Gynaecol 1994;101:669-674
35. Pijnenborg R, Anthony J, Davey DA, Rees A, Tiltman A, Vercruysse L, van Assche A. Placental bed spiral arteries in the hypertensive disorders of pregnancy. Br J Obstet Gynaecol 1991;98:648-655
36. Salafia CM, Ernst L, Pezzullo JC, Wolf EJ, Rosenkrantz TS, Vintzileos AM. The very low birth weight infant, maternal complications leading to preterm birth, placental lesions, and intrauterine growth. Am J Perinatol 1995;12:106-110
37. Khong TY, Liddell HS, Robertson WB. Defective hemochorial placentation as a cause of miscarriage: A preliminary study. Brit J Obstet Gynecol 1987;94:649-655
38. Sheppard BL, Bonnar J. The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by fetal growth retardation. Br J Obstet Gynaecol 1976;83:948-959
39. Brosens IA, Robertson WB, Dixon HG. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977;84:656-663
40. DeWolf F, Brosens I, Renaer M. Fetal growth retardation and the maternal arterial supply of the human placenta in the absence of sustained hypertension. Br J Obstet Gynaecol 1980;87:678-685
41. Naeye RL. Pregnancy hypertension, placental evidences of low uteroplacental blood flow, and spontaneous premature delivery. Hum Pathol 1989;20:441-144
42. Arias F, Rodriquez L, Rayne SC, Kraus FT. Maternal placental vasculopathy and infection: Two distinct subgroups among patients with preterm labor and preterm ruptured membranes. Am J Obstet Gynecol 1993;168:585-591
43. Brosens I, Robertson WB, Dixon HG. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972;1:177-191
44. Robertson WB. Discussion. Pathology of the uteroplacental bed. In Sharp F, Symonds EM (eds). Hypertension in pregnancy. New York: Perinatology Press, 1987:115
45. Pijnenborg R. The human decidua as a passage-way for trophoblast invasion. Trophoblast Rese 1998;11:229-241
46. Khong TY, De Wolf F, Robertson WB, Brosens I. Inadequate maternal vascular response to placentation in pregnancies complicated by preeclampsia and by small-for-gestational age infants. Br J Obstet Gynaecol 1986;93:1049-1059
47. Robertson WB, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol 1967;93:581-592
48. McFadyen IR, Price AB, Geirsson RT. The relation of birth-weight to histological appearances in vessels of the placental bed. Br J Obstet Gynaecol 1986;93:476-481
49. Brosens I, Renaer M. On the pathogenesis of placental infarcts in preeclampsia. J Obstet Gynaecol Br Cwlth 1972;79:794-799
50. Bukovsky A, Labarrere CA, Haag B, Carter C, Faulk WP. Tissue factor in normal and transplanted human kidneys. Transplant 1992;54:644-650
51. Torry RJ, Labarrerre CA, Gargiulo P, Faulk WP. Natural anticoagulant and fibrinolytic pathways in renal allograft failure. Transplant 1994;58:926-935
52. Silver RK, Peaceman AM, Adams DM. Understanding prostaglandin metabolites and platelet-activating factor in the pathophysiology and treatment of the antiphospholipid syndrome. Clin Perinatol 1995;22:357-373
53. Wallenburg HC. Low-dose aspirin therapy in obstetrics. Curr Opin Obstet Gynecol 1995;7:135-139
54. Khong TY, Sawyer IH, Heryet AR. An immunohistologic study of endothelialization of uteroplacental vessels in human pregnancy: Evidence that endothelium is focally disrupted by trophoblast in preeclampsia. Am J Obstet Gynecol 1992;167:751-756
55. Salafia CM, Starzyk KA, Lage JM, Parkash V, Vercruysse L, Pijnenborg R. Lipoprotein(a) deposition in the uteroplacental bed and in basal plate uteroplacental arteries: Atherosclerosis-associated processes in normal and complicated pregnancies. Trophoblast Res 1998;11:377-387
56. Andrew A, Bulmer JN, Morrison L, Wells M, Buckley CH. Subinvolution of the uteroplacental arteries: An immunohistochemical study. Int J Gynecol Pathol 1993;12:28-33
57. Salafia CM, Maier D, Vogel C, Pezzullo J, Burns J, Silberman L. Placental and decidual histology in spontaneous abortion: Detailed description and correlations with chromosome number. Obstet Gynecol 1993;82:295-303
58. Erlendsson K, Steinsson K, Johannsson JH, Giersson RT. Relation of antiphospholipid antibody and placental bed inflammatory vascular changes to the outcome of pregnancy in successive pregnancies of 2 women with systemic lupus erythematosus. J Rheumatol 1993;20:1779-1785
59. Trudinger BJ, Giles WB, Cook CM. Uteroplacental blood flow velocity-time waveforms in normal and complicated pregnancy. Br J Obstet Gynecol 1985;92:39
60. Lunell NO, Lewander R, Mamoun I, Nylund L, Sarby S, Thornstrom S. Uteroplacental blood flow in pregnancy induced hypertension. Scand J Clin Lab Invest 1984;(Suppl):169:28
61. Murakoshi T, Sekizuka N, Takakuwa K, Yoshizawa H, Tanaka K. Uterine and spiral artery flow velocity waveforms in pregnancy-induced hypertension and/or intrauterine growth retardation. Ultrasound Obstet Gynecol 1996;7:122-128
62. Olofsson P, Laurini RN, Marsal K. A high uterine artery pulsatility index reflects a defective development of placental bed spiral arteries in pregnancies complicated by hypertension and fetal growth retardation. Eur J Obstet Gynecol Reprod Biol 1993;49:161-168
63. Aplin JD, Charlton AK, Ayad S. An immunohistochemical study of human endometrial extracellular matrix during the menstrual cycle and first trimester of pregnancy. Cell Tissue Res 1988;253:231-240
64. Ballegeer V, Spitz B, Kieckens L, Moreau H, Van Assche A, Collen D. Predictive value of increased plasma levels of fibronectin in gestational hypertension. Am J Obstet Gynecol 1989;161:432-436
65. Lazarchick J, Stubbs TM, Romein L, Van Dorsten JP, Load-holt CB. Predictive value of fibronectin levels in normotensive gravid women destined to become preeclamptic. Am J Obstet Gynecol 1986;154:1050-1052
66. Lockwood CJ, Peters JH. Increased plasma levels of ED1+ cellular fibronectin precede the clinical signs of preeclampsia. Am J Obstet Gynecol 1990;162:358-362
67. Ulloa-Aguirre A, August AM, Golos TG, Kao LC, Sakuragi N, Kliman HJ, Strauss JF. 3d. 8-Bromo-adenosine 3′,5′-monophosphate regulates expression of chorionic gonadotropin and fibronectin in human cytotrophoblasts. J Clin Endocrinol Metab 1987;64:1002-1009
68. Pijnenborg R, Vercruysse L, Ballegeer V. The distribution of fibronectin in the placental bed in normotensive and hypertensive human pregnancies. Trophoblast Res 1992;6:343-350
69. Aplin JD. Expression of integrin a6b4 in human trophoblast and its loss from extravillous cells. Placenta 1993;14:203-214
70. Damsky CH, Fitzgerald ML, Fisher SJ. Distribution patterns of extracellular matrix components and adhesion receptors are intricately modulated during first trimester cytotrophoblast differentiation along the invasive pathway, in vivo. J Clin Invest 1992;89:210-222
71. Zhou Y, Damsky CH, Chiu K, Roberts JM, Fisher SJ. Preeclampsia is associated with abnormal expression of adhesion molecules by invasive cytotrophoblasts. J Clin Invest 1993;91:950-960
72. Divers MJ, Bulmer JN, Miller D, Lilford RF. Beta 1 integrins in third trimester human placentae no differential expression in pathological pregnancy. Placenta 1995;16:245-260
73. Pijnenborg R, Luyten C, Vercruysse L, Van Assche FA. Attachment and differentiation in vitro of trophoblast from normal and preeclamptic human pregnancies. Am J Obstet Gynecol 1996;175:30-36
74. Bischof P, Martelli M. Proteolysis in the penetration phase of the implantation process. Placenta 1992;13:17-24
75. Lala PK, Hamilton GS. Growth factors, proteases and protease inhibitors in the maternal-fetal dialogue. Placenta 1996;17:545-555
76. Polette M, Birembaut P. Membrane - type metalloproteinases in tumor invasion. Int J Biochem Cell Biol 1998;30:1195-1202
77. Laviades C, Varo N, Fernandez J, Mayor G, Gil MJ, Monreal I, Diez J. Abnormalities of the extracellular degradation of collagen type I in essential hypertension. Circulation 1998;98:535-540
78. Moll UM, Lane BL. Proteolytic activity of first trimester human placenta: Localization of interstitial collagenase in villous and extravillous trophoblast. Histochemistry 1990;94:555-560
79. Nawrocki B, Polette M, Marchand V, Maquoi E, Beorchia A, Tournier JM, Foidart JM, Birembaut P. Membrane-type matrix metalloproteinase-1 expression at the site of human placentation. Placenta 1996;17:565-572
80. Polette M, Nawrocki B, Pintiaux A, Massenat C, Maquoi E, Volders L, Schaaps JP, Birembaut P, Foidart JM. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Laboratory Investigation 1994;71:838-846
81. Graham CH, McCrae KR. Altered expression of gelatinase and surface-associated plasminogen activator activity by trophoblast cells isolated from placentas of preeclamptic patients. Am J Obstet Gynecol 1996;175:555-562
82. Shimonovitz S, Hurwitz A, Hochner-Celnikier D, Dushnik M, Anteby E, Yagel S. Expression of gelatinase B by trophoblast cells: Down-regulation by progesterone. Am J Obstet Gynecol 1998;178:457-161
83. Klimek J, Wozniak M, Szymanska G, Zelewski L. Inhibitory effect of free radicals derived from organic hydroperoxide on progesterone synthesis in human term placental mitochondria. Free Radic Biol Med 1998;24:1168-1175
84. Chen HL, Yang Y, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991;139:327-335
85. Hofmann GE, Horowitz G, Scott RT Jr, Navot D. Transforming growth factor a in human implantation trophoblast: Immunohistochemical evidence for autocrine/ paracrine function. J Clin Endocr Metab 1993;76:781-785
86. Simon C, Frances A, Piquette G, Hendrickson M, Milki A, Polan ML. Interleukin-1 system in the materno-trophoblast unit in human implantation: Immunohistochemical evidence for autocrine/paracrine function. J Clin Endocr Metab 1994;78:847-854
87. Selick CE, Horowitz GM, Gratch M, Scott RT Jr, Navot D, Hofmann GE. Immunohistochemical localization of transforming growth factor-beta in human implantation sites. J Clin Endocr Metab 1994;78:592-596
88. Lysiak JJ, Hunt J, Pringle GA, Lala PK. Localization of transforming growth factor βand its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta 1995;16:221-231
89. Jokhi PP, Chumbley G, King A, Gardner L, Loke YW. Expression of the colony stimulating factor 1 receptor (c-fms product) by cells at the human uteroplacental interface. Lab Invest 1993;68:308-320
90. Jokhi PP, King A, Loke YW. Reciprocal expression of epidermal growth factor receptor (EGF-R) and c-erbB2 by non-invasive and invasive human trophoblast populations. Cytokine 1994;6:433-442
91. Hara N, Fujii T, Okai T, Taketani Y. Histochemical demonstration of interleukin-2 in decidual cells of patients with preeclampsia. Amer J Reprod Immunol 1995;34:44-51
92. Keith JC Jr, Pijnenborg R, Spitz B, Hanssens M, Van Assche FA. Assessment of differential serum cytotoxicity in gestational hypertension using a fibrosarcoma cell line and the MTT assay. Hyperten Preg 1995;14:81-90
93. Keith JC Jr, Rowles TK, Dilorenzo K, Mishra S, Misra HP. Preeclampsia. J Perinatol 1993;13:417-418
94. Meekins JW, McLaughlin PJ, West DC, McFadyen IR, Johnson PM. Endothelial cell activation by tumour necrosis factor-alpha (TNF-α) and the development of preeclampsia. Clin Exp Immunol 1994;98:110-114
95. Visser W, Beckmann I, Bremer HA, Lim HL, Wallenburg HC. Bioactive tumor necrosis factor-a in pre-eclamptic patients with and without the HELLP syndrome. Br J Obstet Gynaecol 1994;101:1081-1082
96. Pijnenborg R, McLaughlin PJ, Vercruysse L, Hanssens M, Johnson PM, Kieth JC, Van Assche FA. Immunolocalization of tumor necrosis factor-α(TNF-α) in the placental bed of normotensive and hypertensive human pregnancies. Placenta 1998;19:231-239
97. Hunt JS, Chen HL, Miller L. Tumor necrosis factors: Pivotal components of pregnancy? Biol Reprod 1996;54:554-562
98. de Vries JI, Dekker GA, Huijgens PC, Jakobs C, Blomberg BM, van Geijn HP. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies. Br J Obstet Gynaecol 1997;104:1248-1254
99. Berg K, Roald B, Sande H. High Lp(a) lipoprotein level in maternal serum may interfere with placental circulation and cause fetal growth retardation. Clin Genet 1994;46:52-56
100. Meekins JW, Pijnenborg R, Hanssens M, van Assche A, McFadyen IR. Immunohistochemical detection of lipopro-tein(a) in the wall of placental bed spiral arteries in normal and severe preeclamptic pregnancies. Placenta 1991;15:511-524
101. Ross R. The pathogenesis of atherosclerosis: An update. N Engl J Med 1986;314:488-500
102. Redman CWG. Current Topic: Preeclampsia and the placenta. Placenta 1991;12:301-308
103. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GH, Bromberg IL, Cerone R. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet, 1985;37:1-31
104. Clarke R, Daly L, Robinson K, Naugthen E, Cahalane S Fowler B, Graham I. Hyperhomocysteinemia: An independent risk factor for vascular disease. N Engl J Med 1991;324:1149-1155
105. Wouters MGAJ, Boers GHJ, Blom HJ, Trijbels FJM, Thomas CMG, Borm GF, Steegers-Theunissen RP, Eskes TK. Hyperhomocysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss. Fertil Steril 1993;60:820-824
106. Quere I, Bellet H, Hoffet M, Janbon C, Mares P, Gris J-C. A woman with five consecutive fetal deaths: Case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriages. Fertil Steril 1998;69:152-154
107. Goddijn-Wessel TAW, Wouters MGAJ, v.d. Molen EF, Spuijbroek MD, Steegers-Theunissen RP, Blom HJ, Boers GH, Eskes TK. Hyperhomocysteinemia: A risk factor for placental abruption or infarction. Eur J Obstet Gynaecol Reprod Biol 1996;66:23-29
108. Lentz SR. Homocysteine and vascular dysfunction. Life Sci 1997;61:1205-1215
109. Harpel PC, Borth W. Fibrin, lipoprotein(a), plasmin interactions. A model linking thrombosis and atherogenesis. Ann NY Acad Sci 1992;233-238
110. Ridker PM, Miletich JP, Buring JE, Ariyo AA, Price DT, Manson JE, Hill JA. Factor V Leiden mutation as a risk factor for recurrent pregnancy loss. Ann Intern Med 1998;128(Pt 1):1000-1003
111. Arias F, Romero R, Joist H, Kraus FT. Thrombophilia: A mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med 1998;7:277-286
112. Krauss T, Augustin HG, Osmers R, Meden H, Unterhalt M, Kuhn W. Activated protein C resistance and factor V Leiden in patients with hemolysis, elevated liver enzymes, low platelets syndrome. Obstet Gynecol 1998;92:457-460
113. Walker MC, Garner PR, Keely EJ, Rock GA, Reis MD. Changes in activated protein C resistance during normal pregnancy. Am J Obstet Gynecol 1997;177:162-169